Our mission is to impact patient lives globally by making cell therapies scalable, accessible and commercially viable.
Stages
We build and invest from pre-seed onwards
Region
London, Cambridge
Strategic Focus Area
Cell therapy (therapeutics, services and manufacturing technologies)
Cell therapy represents one of the most important therapeutic paradigms emerging to treat some of our most pernicious diseases. It is not only upending how patients are treated, but is also disrupting the way therapies are developed, manufactured, and delivered to patients – which creates new unmet needs and exciting business opportunities.
Delin’s goal is to position itself at the nexus of this opportunity, being the pre-eminent investment company in promising cell therapies and the infrastructure that enables their development and commercialization.
